Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Kin Meds vs Vytora Health

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Kin Meds logo

Kin Meds

7.4
★★★3.7/5

Best for: compounded and brand-name GLP-1 plus a longevity stack on one platform

Visit Kin Meds
VS
Vytora Health logo

Vytora Health

8.4
★★★★4.2/5

Best for: compounded or brand-name GLP-1 with named pharmacy partners, 50 states

Visit Vytora Health

Kin Meds and Vytora Health are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, Kin Meds starts lower at $149/mo versus $150/mo, and Vytora Health edges ahead overall (8.4 vs 7.4 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.

Pricing

Kin Meds

Personalized GLP-1 (compounded semaglutide, starting)Compounded
$199$146/mo
Save 27% right now
semaglutide

$53 off first order, applied automatically at checkout per kinmeds.com/glp1-discount ('Save $53 on first order -Discount applied at checkout')

Personalized GLP-1/GIP (compounded tirzepatide, starting)Compounded
$249$196/mo
Save 21% right now
tirzepatide

$53 off first order, auto-applied; discount page quotes starting dose 'as low as $49/week' first month

Brand Wegovy injection/pill (entry pricing)Brand-name
$149/mo
semaglutide

Entry pricing — likely insured/savings-card tier; cash-pay NovoCare standard pen is $299/mo (oral pill $149)

Brand Zepbound pen/vial (entry pricing)Brand-name
$149/mo
tirzepatide

Entry pricing — likely insured/savings-card tier; cash-pay LillyDirect vials run $299-$449/mo

Brand Foundayo (entry pricing)Brand-name
$149/mo
orforglipron

Matches the LillyDirect $149/mo starter cash price for Foundayo

Vytora Health

All dosesCompounded
$180/mo
semaglutide
3-mo bundle ($450 billed)Compounded
$150/mo
semaglutide
All dosesCompounded
$249/mo
tirzepatide
3-mo bundle ($599 billed)Compounded
$200/mo
tirzepatide
Brand 5/7.5/10/12.5/15 mgBrand-name
$1399/mo
mounjaro
Brand 2.5/5/7.5/10/12.5/15 mgBrand-name
$1399/mo
zepbound

Get alerted when GLP-1 prices drop

Join the GLP-1 price-watch list — we re-verify 390+ providers' prices on their own sites and email you when tracked prices move.

What’s included

Kin Meds

Inclusions not disclosed.

Vytora Health

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

Kin Meds

7.4/10

Overall

Vytora Health

8.4/10

Value25%

7.5A
vs
B
8.0

Effectiveness25%

7.5A
vs
B
8.5

User Experience15%

7.5A
vs
B
8.0

Trust & Safety15%

7.3A
vs
B
9.3

Accessibility10%

7.0A
vs
B
8.5

Support10%

7.4A
vs
B
8.4

Features & Coverage

FeatureKin MedsVytora Health
Starting Price$149/mo$150/mo
Features8 features8 features
States AvailableNot disclosed51
Compounded✓ Yes✓ Yes
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

About Kin Meds

Kin Meds is a LegitScript-verified telehealth platform offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options including Wegovy injection and pill, Zepbound and Foundayo from $149/mo. Beyond weight loss, it bundles a longevity and wellness menu — Sermorelin, NAD+, glutathione, TRT, plus hair, skin and sexual health — so members can manage multiple protocols on one account.

Read our full Kin Meds review →

About Vytora Health

Vytora Health is a 50-state-plus-DC telehealth platform offering compounded semaglutide and tirzepatide alongside brand-name Mounjaro and Zepbound, plus NAD+ and sermorelin peptides. It names its pharmacy partners publicly — Vials Pharmacy and Greenwich Biosciences — and discloses its operating physician group, uncommon transparency for the category. Compounded semaglutide runs $180/mo ($150 on a 3-month bundle) and tirzepatide $249/mo ($200 bundled).

Read our full Vytora Health review →

Pros & Cons

Kin Meds

What we like

  • Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
  • Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
  • LegitScript verified
  • Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
  • Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health
  • Telehealth flow clearly disclosed: questionnaire, provider review, tailored plan, ongoing support

Watch-outs

  • Legal entity name and state of incorporation not publicly disclosed
  • The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
  • Per-state availability not listed
  • $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
  • Lab work and dose-titration support not clearly described
  • Breadth across 8+ categories signals a broad DTC platform, not a GLP-1 specialist

Vytora Health

What we like

  • All 50 states plus DC, with per-state video-vs-audio compliance disclosed
  • Both compounded and brand-name options on one platform — uncommon
  • LegitScript Approved and HIPAA compliant
  • Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
  • Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)
  • Competitive monthly pricing ($180 sema / $249 tirz) plus a 3-month bundle saving 17%
  • Brand-name Mounjaro and Zepbound available at $1,399/mo for FDA-approved options

Watch-outs

  • Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
  • Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
  • Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
  • Initial consultation cost not shown on the public pricing page
  • Limited per-prescriber state licensure detail

Our Verdict

Winner: Vytora Health

Vytora Health edges out Kin Meds with a higher overall score of 8.4/10 and is particularly strong for compounded or brand-name GLP-1 with named pharmacy partners, 50 states. Kin Meds remains a solid alternative, especially if you're looking for compounded and brand-name GLP-1 plus a longevity stack on one platform.

Choose Kin Meds if…

You want compounded and brand-name GLP-1 plus a longevity stack on one platform and a starting price around $149/mo.

Choose Vytora Health if…

You want compounded or brand-name GLP-1 with named pharmacy partners, 50 states and a starting price around $150/mo.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.5

PeterMD

Men seeking flat-priced compounded GLP-1 access alongside TRT or peptide therapy

7.8

Care Bare Rx

LGBTQ+-inclusive compounded GLP-1 telehealth

8.2

Enhance MD

Lab-monitored compounded GLP-1 with mandatory video visit

Kin Meds vs Vytora Health: FAQ

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Continue exploring Kin Meds and Vytora Health head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.